Current status: 873 hESC lines, 3634 hiPSC lines, and 111 clinical studies, and 523 certificates
Monthly statistic from Mar 1, 2023
Posted on March 1, 2023
| total lines | 4507 |
| hESC lines | 873 |
| hiPSC lines | 3634 |
| derivation countries | 45 |
| projects | 261 |
| providers | 798 |
| clinical studies | 111 |
| subclones | 2036 |
| certificates | 523 |
| cell line certificates | 390 |
| project certificates | 133 |